European Commission funds NUDZ·$0.22mLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnPfizer buys Metsera·no dollar priceAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·no dollar priceAbbVie takes an option on Gilgamesh·$2bnEuropean Commission funds NUDZ·$0.22mLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnPfizer buys Metsera·no dollar priceAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·no dollar priceAbbVie takes an option on Gilgamesh·$2bnEuropean Commission funds NUDZ·$0.22mLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnPfizer buys Metsera·no dollar priceAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·no dollar priceAbbVie takes an option on Gilgamesh·$2bn
Next issueIssue 23 · Tue 17 Nov 

Companies

Pfizer

Pfizer Inc.

HQ
United States
Registry
SEC EDGAR · CIK 78003
Status
active
Listing
Listed · PFE
Current stage
commercial

sec.govregistryverified 2026-11-10

Notes on the record

Not a psychedelic company. Acquirer in D007-pfizer-metsera-2025, the row that ties the Metsera CVR to CUSIP 592CVR013 for the CVR-holder work. Added 2026-11-10 because the site build fails without it: the deal tape resolves every deals.csv party through this file (src/components/Tape.astro), and production deploys on main had failed since D007 merged. Pfizer 8-K 0000078003-25-000159, Item 8.01: on November 13, 2025 Pfizer completed the acquisition of Metsera, Inc. EDGAR submissions API read 2026-11-10: name PFIZER INC, ticker PFE, state of incorporation DE.

Assets

No asset in data/assets.csv names this company as owner.

Registered trials

No row in data/trials.csv resolves to this company's assets.

Deals

In the briefing

No published issue carries the PFIZER tag.